Skip to main content

Advertisement

Log in

May an adrenal incidentaloma change its nature?

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background

Up to 70% of adrenal masses detected in patients affected by extra-adrenal malignancy are metastatic lesions. Therefore, detection of an adrenal mass in patients with active or previous malignancy requires a careful differential diagnostic workup. 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) is increasingly being used to determine the malignant potential of adrenal lesions.

Clinical case

We report the case of a 64-year-old man who had a single adrenal metastasis due to non-small-cell lung carcinoma developing on a pre-existing benign adrenal lesion. This metastasis occurred in a phase of perceived oncological remission and was detected thanks to 18F-FDG-PET/CT showing a focal adrenal uptake. Contrast-enhanced computed tomography (CT), performed as part of oncological follow-up, and MRI with chemical shift sequences did not lead to the correct diagnosis. The patient underwent laparoscopic adrenalectomy and the pathological evaluation confirmed a lung carcinoma metastasis.

Conclusion

The present case highlights the peculiarity of the follow-up of adrenal masses in cancer patients and the primary role of 18F-FDG-PET/CT in the management of such patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G et al (2011) AME position statement on adrenal incidentaloma. Eur J Endocrinol 164:851–870

    Article  CAS  PubMed  Google Scholar 

  2. Cingam SR, Karanchi H (2019) Cancer, adrenal metastasis. StatPearls Publishing

  3. Untch BR, Shia J, Downey RJ, Carrasquillo JA, Panicek DM, Strong VE (2014) Imaging and management of a small cell lung cancer metastasis/adrenal adenoma collision tumor: a case report and review of the literature. World J Surg Oncol 12:45

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A et al (2016) Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 175:G1–G34

    Article  CAS  PubMed  Google Scholar 

  5. Elhassan YS, Alahdab F, Prete A, Delivanis DA, Khanna A, Prokop L et al (2019) Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis. Ann Intern Med 171:107–116

    Article  PubMed  Google Scholar 

  6. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411–1415

    Article  CAS  PubMed  Google Scholar 

  7. Peña CS, Boland GW, Hahn PF, Lee MJ, Mueller PR (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced. CT Radiol 217:798–802

    Article  Google Scholar 

  8. Zhang HM, Perrier ND, Grubbs EG, Sircar K, Ye ZX, Lee JE et al (2012) CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clin Radiol 67:38–46

    Article  CAS  PubMed  Google Scholar 

  9. Dunnick NR, Korobkin M (2002) Imaging of adrenal incidentalomas: current status. AJR Am J Roentgenol 179:559–568

    Article  PubMed  Google Scholar 

  10. Haider MA, Ghai S, Jhaveri K, Lockwood G (2004) Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 231:711–716

    Article  PubMed  Google Scholar 

  11. Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB et al (2011) Adrenocortical carcinoma: the range of appearances on CT and MRI. AJR Am J Roentgenol 196:W706–W714

    Article  PubMed  Google Scholar 

  12. Zukotynski K, Lewis A, O'Regan K, Jacene H, Sakellis C, Krajewski K et al (2012) PET/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology. AJR Am J Roentgenol 199:W163–W167

    Article  PubMed  Google Scholar 

  13. Alencar GA, Fragoso MC, Yamaga LY, Lerario AM, Mendonca BB (2011) (18)F-FDG-PET/CT imaging of ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) demonstrating increased (18)F-FDG uptake. J Clin Endocrinol Metab 96:3300–3301

    Article  CAS  PubMed  Google Scholar 

  14. Ansquer C, Scigliano S, Mirallié E, Taïeb D, Brunaud L, Sebag F et al (2010) 18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation. Eur J Nucl Med Mol Imaging 37:1669–1678

    Article  PubMed  Google Scholar 

  15. Guerin C, Pattou F, Brunaud L, Lifante JC, Mirallié E, Haissaguerre M et al (2017) Performance of 18F-FDG PET/CT in the characterization of adrenal masses in noncancer patients: a prospective study. J Clin Endocrinol Metal 102:2465–2472

    Article  Google Scholar 

  16. Dinnes J, Bancos I, Ferrante di Ruffano L, Chortis V, Davenport C, Bayliss S et al (2016) Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses—a systematic review and meta-analysis. Eur J Endocrinol 175:R51–R64

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Albano D, Agnello F, Midiri F, Pecoraro G, Bruno A, Alongi P et al (2019) Imaging features of adrenal masses. Insights Imaging 10:1

    Article  PubMed  PubMed Central  Google Scholar 

  18. Twomey P, Montgomery C, Clark O (1982) Successful treatment of adrenal metastases from large-cell carcinoma of the lung. JAMA 248:581–583

    Article  CAS  PubMed  Google Scholar 

  19. Vazquez BJ, Richards ML, Lohse CM, Thompson GB, Farley DR, Grant CS et al (2012) Adrenalectomy improves outcomes of selected patients with metastatic carcinoma. World J Surg 36:1400–1405

    Article  PubMed  Google Scholar 

  20. Higashiyama M, Doi O, Kodama K, Yokouchi H, Imaoka S, Koyama H (1994) Surgical treatment of adrenal metastasis following pulmonary resection for lung cancer: comparison of adrenalectomy with palliative therapy. Int Surg 79:124–129

    CAS  PubMed  Google Scholar 

  21. Kim SH, Brennan MF, Russo P, Burt ME, Coit DG (1998) The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 82:389–394

    Article  CAS  PubMed  Google Scholar 

  22. Porte H, Siat J, Guibert B, Lepimpec-Barthes F, Jancovici R, Bernard A et al (2001) Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. Ann Thorac Surg 71:981–985

    Article  CAS  PubMed  Google Scholar 

  23. Pfannschmidt J, Schlolaut B, Muley T, Hoffmann H, Dienemann H (2005) Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer. Lung Cancer 49:203–207

    Article  PubMed  Google Scholar 

  24. Tanvetyanon T, Robinson LA, Schell MJ, Strong VE, Kapoor R, Coit DG et al (2008) Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol 26:1142–1147

    Article  PubMed  Google Scholar 

  25. Raz DJ, Lanuti M, Gaissert HC, Wright CD, Mathisen DJ, Wain JC (2011) Outcomes of patients with isolated adrenal metastasis from non-small cell lung carcinoma. Ann Thorac Surg 92:1788–1793

    Article  PubMed  Google Scholar 

  26. Ramsingh J, O'Dwyer P, Watson C (2019) Survival outcomes following adrenalectomy for isolated metastases to the adrenal gland. Eur J Surg Oncol 45:631–634

    Article  PubMed  Google Scholar 

  27. Marangos IP, Kazaryan AM, Rosseland AR, Røsok BI, Carlsen HS, Kromann-Andersen B et al (2009) Should we use laparoscopic adrenalectomy for metastases? Scandinavian multicenter study. J Surg Oncol 100:43–47

    Article  PubMed  Google Scholar 

  28. Moreno P, de la Quintana BA, Musholt TJ, Paunovic I, Puccini M, Vidal O et al (2013) Adrenalectomy for solid tumor metastases: results of a multicenter European study. Surgery 154:1215–1223

    Article  PubMed  Google Scholar 

  29. Puccini M, Panicucci E, Candalise V, Ceccarelli C, Neri CM, Buccianti P et al (2017) The role of laparoscopic resection of metastases to adrenal glands. Gland Surg 6:350–354

    Article  PubMed  PubMed Central  Google Scholar 

  30. Drake FT, Beninato T, Xiong MX, Shah NV, Kluijfhout WP, Feeney T et al (2019) Laparoscopic adrenalectomy for metastatic disease: Retrospective cohort with long-term, comprehensive follow-up. Surgery 165:958–964

    Article  PubMed  Google Scholar 

  31. Terzolo M, Reimondo G (2019) Insights on the natural history of adrenal incidentalomas. Ann Intern Med 171:135–136

    Article  PubMed  Google Scholar 

  32. Pakalniskis MG, Ishigami K, Pakalniskis BL, Fujita N (2019) Adrenal collision tumour comprised of adrenocortical carcinoma and myelolipoma in apatient with congenital adrenal hyperplasia. J Med Imaging Radiat Oncol 14:178–182

    Google Scholar 

  33. Foresti M, Parmiggiani A (2019) Adrenal adenoma-hemangioma collision tumor: description of two cases. J Radiol Case Rep 13:1–12

    PubMed  PubMed Central  Google Scholar 

  34. Khorsand A, Khatami F, Sefidbakht S, Saffar H, Sadeghipour A, Tavangar SM (2018) Adrenal collision tumor composed of pheochromocytoma and diffuse large B-cell lymphoma: a case report. Int J Hematol Oncol Stem Cell Res 12:249–252

    PubMed  PubMed Central  Google Scholar 

  35. Lai Y, Zhou L, Hu J, Li W, Cui L, Lai Y, Ni L (2018) Erratum: adrenal collision tumor (parachordoma and ganglioneuroma): a case report. Mol Clin Oncol 9:238

    PubMed  PubMed Central  Google Scholar 

  36. Zhang CX, Tian Y (2018) Adrenal collision tumor composed of adrenocortical adenoma and pheochromocytoma. Chin Med J (Engl) 131:374–375

    Article  Google Scholar 

  37. Liu D, Kumar SA (2017) An exceedingly rare adrenal collision tumor: adrenal adenoma-metastatic breast cancer-myelolipoma. J Community Hosp Intern Med Perspect 7:241–244

    Article  PubMed  PubMed Central  Google Scholar 

  38. Takizawa K, Kohashi K, Negishi T, Taguchi K, Yamada Y, Nakamura M et al (2017) A exceptional collision tumor of primary adrenal angiosarcoma and non-functioning adrenocortical adenoma. Pathol Res Pract 213:702–705

    Article  CAS  PubMed  Google Scholar 

  39. Lee HS, Choi YJ, Kim C, Kim BH (2016) Adrenal collision tumor: coexistence of pigmented adrenal cortical Oncocytoma and Ganglioneuroma. Case Rep Surg 2016:5790645

    PubMed  PubMed Central  Google Scholar 

  40. Piotrowski Z, Tomaszewski JJ, Hartman AL, Edwards K, Uzzo RG (2015) Renal cell carcinoma and an incidental adrenal lesion: adrenal collision tumors. Urology 85:e17–e18

    Article  PubMed  Google Scholar 

  41. Hayashi T, Gucer H, Mete O (2014) A mimic of sarcomatoid adrenal cortical carcinoma: epithelioid angiosarcoma occurring in adrenal cortical adenoma. Endocr Pathol 25:404–409

    Article  PubMed  Google Scholar 

  42. Wang J, Fisher C, Thway K (2014) “Dominant” myelolipoma encasing adrenal cortical carcinoma: an unusual variation of myelolipoma occurring as a synchronous and predominant neoplasm. Int J Surg Pathol 22:731–735

    Article  PubMed  Google Scholar 

  43. Abdullazade IS, Tezel G (2012) A rare case of collision tumor: coexistence of adrenocortical adenoma and pheochromocytoma in the same adrenal gland. J Med Cases 3:63–67

    Google Scholar 

  44. Siddiqi AJ, Miller FH, Kasuganti D, Nikolaidis P (2009) Adrenal hemangioma-adenoma: an exceedingly rare adrenal collision tumor. J Magn Reson Imaging 29:949–952

    Article  PubMed  Google Scholar 

  45. Bertolini F, Rossi G, Fiochhi F, Giacometti M, Fontana A, Gibertini MC et al (2011) Primary adrenal gland carcinosarcoma associated with metastatic rectal cancer: a hitherto unreported collision tumor. Tumori 97:27e–30e

    Article  PubMed  Google Scholar 

  46. Thorin-Savoure A, Tissier-Rible F, Guignat L, Pellerin A, Bertagna X, Bertherat J et al (2005) Collision/composite tumors of the adrenal gland: a pitfall of scintigraphy imaging and hormone assays in the detection of adrenal metastasis. J Clin Endo Metabol 90:4924–4929

    Article  CAS  Google Scholar 

  47. Hagspeil KD (2005) Manifestation of Hodgkin’s lymphoma in an adrenal myelolipoma. Eur Radiol 15:1757–1759

    Article  Google Scholar 

  48. Blake MA, Sweeney AT, Kalra MK, Maher MM (2004) Collision adrenal tumors on PET/CT. AJR Am J Roentgenol 183:864–865

    Article  PubMed  Google Scholar 

  49. Otal P, Escourrou G, Mazerolles C, Janne d’Othee B, Mezghani S, Musso S et al (1999) Imaging features of uncommon adrenal masses with histopathologic correlation. Radiographics 19:569–581

    Article  CAS  PubMed  Google Scholar 

  50. Schwartz LH, Macari M, Huvos AG, Panicek DM (1996) Collision tumors of the adrenal gland: demonstration and characterization at MR imaging. Radiology 201:757–760

    Article  CAS  PubMed  Google Scholar 

  51. Hoshi H, Jinnouchi S, Ono S, Kihara Y, Arakawa K, Takeuchi M et al (1984) Scintigraphic demonstration of coexisting adenoma and metastasis of the adrenal gland in a patient with bronchogenic carcinoma. Clin Nucl Med 9:717–718

    Article  CAS  PubMed  Google Scholar 

  52. Kandathil A, Wong KK, Wale DJ, Zatelli MC, Maffione AM, Gross MD et al (2015) Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature. Endocrine 49:6–26

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Clinical management of the patient: AP; imaging review: FS; pathological review: EB; drafting of the manuscript: AM, EI; critical review of the manuscript: SP, AP, GR, MT; supervision: AP, GR, MT.

Corresponding author

Correspondence to S. Puglisi.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

All procedures performed in study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from the patient for publication of identifying information and images.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Müller, A., Ingargiola, E., Solitro, F. et al. May an adrenal incidentaloma change its nature?. J Endocrinol Invest 43, 1301–1307 (2020). https://doi.org/10.1007/s40618-020-01219-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-020-01219-3

Keywords

Navigation